Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -119,000 | -121,000 | -4,068,000 | 441,000 | -1,065,000 |
| Depreciation Amortization | 920,000 | 1,165,000 | 5,175,000 | 1,435,000 | 2,698,000 |
| Income taxes - deferred | -397,000 | -223,000 | -166,000 | 46,000 | -110,000 |
| Accounts receivable | 53,000 | -101,000 | 37,000 | 42,000 | 52,000 |
| Other Working Capital | 962,000 | 183,000 | 304,000 | -237,000 | -1,373,000 |
| Other Operating Activity | -150,000 | 207,000 | -2,000 | -719,000 | 123,000 |
| Operating Cash Flow | $1,269,000 | $1,110,000 | $1,280,000 | $1,008,000 | $325,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -259,000 | -192,000 | -210,000 | -288,000 | -267,000 |
| Net Acquisitions | -500,000 | -244,000 | -356,000 | 1,070,000 | -205,000 |
| Purchase Of Investment | N/A | -44,000 | -22,000 | -11,000 | N/A |
| Sale Of Investment | 14,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 5,000 | 9,000 | 5,000 | 4,000 |
| Investing Cash Flow | $-745,000 | $-475,000 | $-579,000 | $776,000 | $-468,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 810,000 | 340,000 | 371,000 | 565,000 | 1,173,000 |
| Debt Issued | N/A | 1,440,000 | N/A | N/A | N/A |
| Debt Repayment | N/A | -1,610,000 | -156,000 | -1,250,000 | -1,712,000 |
| Common Stock Issued | 60,000 | 74,000 | 21,000 | 21,000 | 31,000 |
| Common Stock Repurchased | -125,000 | -500,000 | -600,000 | -492,000 | N/A |
| Other Financing Activity | -895,000 | -368,000 | -400,000 | -572,000 | 0 |
| Financing Cash Flow | $-150,000 | $-624,000 | $-764,000 | $-1,728,000 | $-508,000 |
| Exchange Rate Effect | -4,000 | -1,000 | 3,000 | -2,000 | N/A |
| Beginning Cash Position | 217,000 | 207,000 | 267,000 | 213,000 | 864,000 |
| End Cash Position | 587,000 | 217,000 | 207,000 | 267,000 | 213,000 |
| Net Cash Flow | $370,000 | $10,000 | $-60,000 | $54,000 | $-651,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,269,000 | 1,110,000 | 1,280,000 | 1,008,000 | 325,000 |
| Capital Expenditure | -259,000 | -245,000 | -226,000 | -304,000 | -272,000 |
| Free Cash Flow | 1,010,000 | 865,000 | 1,054,000 | 704,000 | 53,000 |